Cellectar Biosciences, Inc. (CLRB)
2.38
-0.03
(-1.24%)
USD |
NASDAQ |
Sep 09, 13:38
Cellectar Biosciences Total Assets (Quarterly) : 36.64M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.64M |
| March 31, 2026 | 11.12M |
| December 31, 2025 | 14.98M |
| September 30, 2025 | 14.63M |
| June 30, 2025 | 13.70M |
| March 31, 2025 | 16.04M |
| December 31, 2024 | 25.47M |
| September 30, 2024 | 37.29M |
| June 30, 2024 | 29.38M |
| March 31, 2024 | 42.91M |
| December 31, 2023 | 12.08M |
| September 30, 2023 | 21.55M |
| June 30, 2023 | 6.509M |
| March 31, 2023 | 14.84M |
| December 31, 2022 | 21.59M |
| September 30, 2022 | 19.32M |
| June 30, 2022 | 25.89M |
| March 31, 2022 | 31.99M |
| December 31, 2021 | 37.20M |
| September 30, 2021 | 41.95M |
| June 30, 2021 | 47.74M |
| March 31, 2021 | 55.06M |
| December 31, 2020 | 58.66M |
| September 30, 2020 | 20.70M |
| June 30, 2020 | 23.85M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.690M |
| December 31, 2019 | 12.25M |
| September 30, 2019 | 15.66M |
| June 30, 2019 | 19.14M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 15.05M |
| September 30, 2018 | 19.54M |
| June 30, 2018 | 6.997M |
| March 31, 2018 | 9.561M |
| December 31, 2017 | 12.87M |
| September 30, 2017 | 9.871M |
| June 30, 2017 | 12.60M |
| March 31, 2017 | 15.30M |
| December 31, 2016 | 15.32M |
| September 30, 2016 | 9.296M |
| June 30, 2016 | 11.38M |
| March 31, 2016 | 5.570M |
| December 31, 2015 | 7.596M |
| September 30, 2015 | 6.462M |
| June 30, 2015 | 8.580M |
| March 31, 2015 | 10.91M |
| December 31, 2014 | 13.42M |
| September 30, 2014 | 15.72M |
| June 30, 2014 | 5.889M |
| March 31, 2014 | 8.040M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.767M |
| Shareholders Equity (Quarterly) | 29.87M |
| Debt to Equity Ratio | 0.0513 |
| Current Ratio | 6.659 |
| Net Debt Paydown Yield | -0.92% |